Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ITI Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited15.183219988133.5320
Domestic EquitiesDivi's Laboratories Limited9.12483047820.1521
Domestic EquitiesMax Healthcare Institute Limited5.423310644511.9772
Domestic EquitiesLupin Limited5.39946091011.9244
Domestic EquitiesApollo Hospitals Enterprise Limited5.19291666811.4684
Domestic EquitiesCohance Lifesciences Limited4.843810210410.6974
Domestic EquitiesAurobindo Pharma Limited3.9298756148.6790
Domestic EquitiesTorrent Pharmaceuticals Limited3.9125272178.6406
Domestic EquitiesAster DM Healthcare Limited3.15201244626.9612
Domestic EquitiesMankind Pharma Limited3.0419272246.7181
Domestic EquitiesAlkem Laboratories Limited2.8749124536.3492
Domestic EquitiesFortis Healthcare Limited2.4262758645.3583
Domestic EquitiesAbbott India Limited2.330516905.1469
Domestic EquitiesWockhardt Limited2.2836344185.0433
Domestic EquitiesGranules India Limited2.1056876504.6503
Domestic EquitiesNeuland Laboratories Limited1.979838014.3723
Domestic EquitiesFDC Limited1.5483779083.4194
Domestic EquitiesHealthcare Global Enterprises Limited1.5476630133.4178
Domestic EquitiesSupriya Lifescience Limited1.4804451593.2695
Domestic EquitiesSumitomo Chemical India Limited1.4263621603.1500
Domestic EquitiesSagility India Limited1.28937203222.8474
Domestic EquitiesRainbow Childrens Medicare Limited1.2796201502.8260
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited1.2311162192.7188
Domestic EquitiesVijaya Diagnostic Centre Limited1.2274283472.7108
Domestic EquitiesShilpa Medicare Limited1.2250300132.7054
Domestic EquitiesDr. Reddy's Laboratories Limited1.2213215582.6973
Domestic EquitiesGland Pharma Limited1.1818164292.6099
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited1.180979062.6079
Domestic EquitiesUPL Limited1.1369399892.5109
Domestic EquitiesOnesource Specialty Pharma Limited1.0902125272.4077
Domestic EquitiesCaplin Point Laboratories Limited1.0762110412.3767
Domestic EquitiesLinde India Limited1.065431352.3530
Domestic EquitiesOrchid Pharma Limited1.0322362582.2797
Domestic EquitiesCipla Limited1.0233154192.2600
Domestic EquitiesSai Life Sciences Limited1.0164296562.2448
Domestic EquitiesStrides Pharma Science Limited1.0112275332.2332
Domestic EquitiesLaurus Labs Limited0.9665350172.1346
Domestic EquitiesSRF Limited0.926471512.0459
Domestic EquitiesTTK Healthcare Limited0.318457880.7032
Total 99.7065 220.2006
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)0.2935 0.6482
Total 0.2935 0.6482
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.